TY - CHAP M1 - Book, Section TI - Skin Cancer Vaccines A1 - Fayne, Rachel A1 - Nichols, Anna A2 - Nouri, Keyvan Y1 - 2023 N1 - T2 - Skin Cancer: A Comprehensive Guide AB - SUMMARYVaccines are traditionally used for the prevention of infections and related sequelae, but they have been repurposed as a novel treatment platform for several types of cancer.Currently, there is only one skin cancer vaccine (T-VEC; oncolytic herpesvirus vaccine) approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced melanoma. Several other oncolytic virus vaccines and other vaccine platforms are in phases 1, 2, and 3 testing for the treatment of advanced melanoma.The FDA-approved quadrivalent and 9-valent human papillomavirus (HPV) vaccines have been used in a few reports to prevent and treat nonmelanoma skin cancer and show promising initial results. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - dermatology.mhmedical.com/content.aspx?aid=1194728821 ER -